Skip to content

In the BioHarmony Drug Report Database

Choriogonadotropin alfa

Ovidrel, Ovitrelle (choriogonadotropin alfa) is a protein pharmaceutical. Choriogonadotropin alfa was first approved as Ovidrel on 2000-09-20. It is used to treat cryptorchidism, female infertility, and hypogonadism in the USA. It has been approved in Europe to treat anovulation, assisted reproductive techniques, and female infertility.
Trade Name Ovitrelle
Common Name Choriogonadotropin alfa
Indication anovulation, assisted reproductive techniques, cryptorchidism, female infertility, hypogonadism
Drug Class Tricyclic compounds; atropine derivatives
Choriogonadotropin alfa
Get full access now